C92. Il-17 in Lung Immunity, Friend or Foe? 2010
DOI: 10.1164/ajrccm-conference.2010.181.1_meetingabstracts.a5085
|View full text |Cite
|
Sign up to set email alerts
|

Influenza A Inhibits TH17-mediated Immunity Which Is Required For Host Defense Against Staphylococcus Aureus Pneumonia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2011
2011
2011
2011

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…Cytokines more typically associated with T cell signaling cascades are important in the clearance of extracellular bacteria from the airways. Mice with mutations in the Th17 cascade (interleukin-17A [IL-17A] or -F and IL-22) appear to have impaired staphylococcal clearance from the lung, despite increased cytokine production and increased inflammation (1). In contrast, the type I interferon (IFN) cascade contributes directly to pulmonary pathology in response to S. aureus.…”
mentioning
confidence: 99%
“…Cytokines more typically associated with T cell signaling cascades are important in the clearance of extracellular bacteria from the airways. Mice with mutations in the Th17 cascade (interleukin-17A [IL-17A] or -F and IL-22) appear to have impaired staphylococcal clearance from the lung, despite increased cytokine production and increased inflammation (1). In contrast, the type I interferon (IFN) cascade contributes directly to pulmonary pathology in response to S. aureus.…”
mentioning
confidence: 99%